A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
Clinical trial NCT07037862 · RECRUITING
Trial details
- NCT number
- NCT07037862
- Sponsor
- Entrada Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2029-03-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.